Sermonix Pharmaceuticals Shares Encore ELAINE-2 Poster Presentation at 2023 Metastatic Breast Cancer Research Conference

COLUMBUS, Ohio, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovati...

Related Keywords

United States ,Columbus ,Ohio ,American ,Barry Komm ,Paul Plourde ,Simon Jenkins ,Monica Kozlowski ,Eli Lilly ,David Portman ,Elizabeth Attias ,Miriam Portman ,Nasdaq ,Astrazeneca ,Parke Davis Pharmaceuticals ,American Society Of Clinical Oncology ,Ligand Pharmaceuticals Inc ,Sermonix Pharmaceuticals Inc ,Metastatic Breast Cancer Research Conference ,Duke University ,Sermonix Pharmaceuticals ,Pharmaceuticals Inc ,Clinical Oncology ,Annual Meeting ,Ligand Pharmaceuticals ,Anthony Wild ,